3 completed, 1 active not recruiting, 1 recruiting, 1 terminated. 6 Phase 1, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 6 | Completed 3, Active not recruiting 1, Recruiting 1, Terminated 1 |
| Phase 2 | 3 | Completed 1, Recruiting 1, Terminated 1 |
Follow Myxofibrosarcoma: new trials by email Literature Review of Myxofibrosarcoma trials Research Report on Myxofibrosarcoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS) Surgical resection, Proton beam radiation therapy, Pazopanib - Adipocytic Neoplasm, Liposarcoma | Phase 1 / Phase 2 | Recruiting | St. Jude Children's Research Hospital | 139 | 2024-03-27 | 2026-08-03 |
| Nivolumab and BO-112 Before Surgery for the Treatment of Resectable Soft Tissue Sarcoma Definitive Surgical Resection, Nanoplexed Poly I:C BO-112, Nivolumab - Leiomyosarcoma, Malignant Peripheral Nerve Sheath Tumor | Phase 1 | Active not recruiting | Jonsson Comprehensive Cancer Center | 14 | 2020-10-14 | 2026-03-10 |
| Study of DCC-3014 in Combination With Avelumab in Patients With Advanced or Metastatic Sarcomas DCC-3014, Avelumab - Sarcoma, Advanced Sarcoma | Phase 1 | Completed | Memorial Sloan Kettering Cancer Center | 32 | 2020-01-22 | 2025-08-28 |
| CAB-AXL-ADC Safety and Efficacy Study in Adult and Adolescent Patients With Sarcoma CAB-AXL-ADC, PD-1 inhibitor - Undifferentiated Pleomorphic Sarcoma, Myxofibrosarcoma | Phase 1 / Phase 2 | Completed | BioAtla, Inc. | 245 | 2018-02-15 | 2025-09-23 |
| Ribociclib and Doxorubicin in Treating Patients With Metastatic or Advanced Soft Tissue Sarcomas That Cannot Be Removed by Surgery Doxorubicin Hydrochloride, Laboratory Biomarker Analysis, Pharmacological Study - Advanced Soft Tissue Sarcoma, Locally Advanced Angiosarcoma | Phase 1 | Completed | OHSU Knight Cancer Institute | 16 | 2017-03-10 | 2023-08-16 |
| Sapanisertib or Pazopanib Hydrochloride in Treating Patients With Locally Advanced or Metastatic Sarcoma Pazopanib, Pazopanib Hydrochloride, Sapanisertib - High Grade Sarcoma, Metastatic Leiomyosarcoma | Phase 1 / Phase 2 | Terminated | National Cancer Institute (NCI) | 151 | 2015-11-30 | 2022-08-23 |
Dermatofibrosarcoma (6) · Histiocytoma, Malignant Fibrous (5) · Leiomyosarcoma (4) · Neurofibrosarcoma (4) · Sarcoma (4) · Sarcoma, Synovial (4) · Liposarcoma (3) · Disorders of Sex Development (2) · Fibrosarcoma (2) · Hemangiosarcoma (2) · Chondrosarcoma, Extraskeletal Myxoid (1) · Glomus Tumor (1) · Granular Cell Tumor (1) · Hemangioendothelioma, Epithelioid (1) · Histiocytoma, Angiomatoid Fibrous (1)
Neoplasms by Histologic Type (6) · Neoplasms, Connective Tissue (6) · Neoplasms, Connective and Soft Tissue (6) · Neoplasms, Fibrous Tissue (6) · Histiocytoma (5) · Neoplasms (5) · Fibrosarcoma (4) · Neoplasms, Muscle Tissue (4) · Neoplasms, Nerve Tissue (4) · Nervous System Diseases (4) · Nervous System Neoplasms (4) · Neurofibroma (4) · Neuromuscular Diseases (4) · Peripheral Nervous System Diseases (4) · Peripheral Nervous System Neoplasms (4)
Doxorubicin (2) · pazopanib (2) · BO-112 (1) · Ifosfamide (1) · Immune Checkpoint Inhibitors (1) · Nivolumab (1) · Proton Therapy (1) · Radiation (1) · Radiotherapy (1) · avelumab (1) · ribociclib (1) · sapanisertib (1) · selinexor (1)
BioAtla, Inc. (1) · Jonsson Comprehensive Cancer Center (1) · Memorial Sloan Kettering Cancer Center (1) · National Cancer Institute (NCI) (1) · OHSU Knight Cancer Institute (1) · St. Jude Children's Research Hospital (1)
United States (6) · Hong Kong (1) · Taiwan (1)
Jessica Gartrell, MD (1) · Lara E Davis (1) · Sandra D'Angelo, MD (1) · Vishruth Reddy, MD, PhD (1) · William D Tap (1)
K08CA245181 (1), U10CA180821 (1)